J
Justine K. Lalonde
Researcher at Hoffmann-La Roche
Publications - 15
Citations - 1561
Justine K. Lalonde is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Binge-eating disorder & Bulimia nervosa. The author has an hindex of 13, co-authored 15 publications receiving 1442 citations. Previous affiliations of Justine K. Lalonde include McLean Hospital & AstraZeneca.
Papers
More filters
Journal ArticleDOI
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Lesley M. Arnold,Don L. Goldenberg,Sharon B. Stanford,Justine K. Lalonde,H. S. Sandhu,Paul E. Keck,Jeffrey A. Welge,Fred Bishop,Kevin E. Stanford,Evelyn V. Hess,James I. Hudson +10 more
TL;DR: Gabapentin (1,200-2,400 mg/day) is safe and efficacious for the treatment of pain and other symptoms associated with fibromyalgia and was generally well tolerated.
Journal ArticleDOI
Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder
James I. Hudson,Justine K. Lalonde,Caitlin E. Coit,Ming T. Tsuang,Ming T. Tsuang,Susan L. McElroy,Scott J. Crow,Cynthia M. Bulik,Margo S. Hudson,Jack A. Yanovski,Norman R. Rosenthal,Harrison G. Pope +11 more
TL;DR: Binge-eating disorder may confer a risk of components of the metabolic syndrome over and above the risk attributable to obesity alone over and over.
Journal ArticleDOI
Co-occurrence of binge eating disorder with psychiatric and medical disorders.
Kristin N. Javaras,Harrison G. Pope,Justine K. Lalonde,Justine K. Lalonde,Jacqueline L. Roberts,Yael I. Nillni,Nan M. Laird,Cynthia M. Bulik,Scott J. Crow,Susan L. McElroy,B. Timothy Walsh,Ming T. Tsuang,Norman R. Rosenthal,James I. Hudson +13 more
TL;DR: BED and, to a lesser degree, subthreshold BED exhibit substantial lifetime co-occurrence with psychiatric and medical disorders.
Journal ArticleDOI
Binge-Eating Disorder as a Distinct Familial Phenotype in Obese Individuals
James I. Hudson,Justine K. Lalonde,Judith M. Berry,Lindsay J. Pindyck,Cynthia M. Bulik,Scott J. Crow,Susan L. McElroy,Nan M. Laird,Ming T. Tsuang,Ming T. Tsuang,B. Timothy Walsh,Norman R. Rosenthal,Harrison G. Pope +12 more
TL;DR: Binge-eating disorder is a familial disorder caused in part by factors distinct from other familial factors for obesity, and these BED-specific familial factors may independently increase the risk of obesity, especially severe obesity.
Journal ArticleDOI
Pharmacologic treatment of binge eating disorder.
William P. Carter,William P. Carter,James I. Hudson,James I. Hudson,Justine K. Lalonde,Justine K. Lalonde,Lindsay J. Pindyck,Susan L. McElroy,Harrison G. Pope,Harrison G. Pope +9 more
TL;DR: The literature offers support for the use of agents from three categories of medication (antidepressants, appetite suppressants, and anticonvulsants) in the treatment of BED.